1,4-二甲氧基-2-(2-甲基丙基)苯 | 89556-61-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,4-二甲氧基-2-(2-甲基丙基)苯
• 英文名称: 1-(2,5-dimethoxyphenyl)-2-methylpropane
• 英文别名: 2-isobutyl-1,4-dimethoxy-benzene；2-Isobutyl-1,4-dimethoxy-benzol；2-isobutyl-1,4-diMethoxybenzene；1,4-dimethoxy-2-(2-methylpropyl)benzene
• CAS: 89556-61-6
• 化学式: C₁₂H₁₈O₂
• 分子量: 194.274
• InChiKey: OBRGZCMAJSEXJM-UHFFFAOYSA-N

物化性质

• 沸点：
  265.3±20.0 °C(Predicted)
• 密度：
  0.953±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1,4-二甲氧基-2-(2-甲基丙基)苯 在 lithium aluminium tetrahydride 、 ammonium acetate 、 四氯化锡 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 8.5h， 生成 1-<2,5-二甲氧基-4-(2-甲基丙基)苯基>-2-氨基丙烷
  参考文献：
  名称：

  Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane

  摘要：

  Two novel hallucinogen analogues related to 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM, STP) were synthesized and evaluated in the two-lever drug discrimination paradigm by using 0.08 mg/kg of LSD as the training drug stimulus. The two compounds differ from each other only with respect to the point of branching in the 4-alkyl group. However, pharmacological evaluation revealed a clear difference in difference in potency and degree of LSD generalization for the two isomers. Branching adjacent to the ring, as in the 4-(2-butyl) analogue, may provide steric interference to the formation of the drug-receptor complex, while branching one methylene unit removed from the ring, as in the 4-(2-methylpropyl) analogue, poses less of a steric problem for the drug-receptor interaction. This is consistent with the idea that formation of a charge-transfer complex between the hallucinogen molecule and the receptor may be one of the features of this drug-receptor interaction.

  DOI：

  10.1021/jm00372a015
• 作为产物：
  描述：

  1-(2,5-二甲氧基苯基)-2-甲基丙烯 在 5%-palladium/activated carbon 、 氢气 作用下， 生成 1,4-二甲氧基-2-(2-甲基丙基)苯
  参考文献：
  名称：

  COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

  摘要：

  本发明涉及具有抗炎性质的化合物和制药组合物。同时提供了使用本发明中的化合物或组合物治疗需要的主题的炎症性疾病的方法。

  公开号：

  US20220119340A1

文献信息

• DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF AS HIF ACTIVATORS
  申请人：ALTENBURGER Jean-Michel

  公开号：US20110294788A1

  公开（公告）日：2011-12-01

  The present invention relates to novel substituted dihydropyrazolone derivatives, to their preparation and to their therapeutic use as activators of the transcription factor HIF.

  本发明涉及新型取代二氢吡唑酮衍生物，其制备以及作为转录因子HIF激活剂的治疗用途。
• POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
  申请人：GLINKA TOMASZ

  公开号：US20080318957A1

  公开（公告）日：2008-12-25

  Disclosed are compounds having polybasic functionalities. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism.

  揭示了具有多元碱功能的化合物。这些化合物抑制细菌外流泵抑制剂，并与抗菌剂结合使用以治疗或预防细菌感染。这些组合物可以有效对抗通过外流泵机制对抗菌剂产生抗药性的细菌感染。
• Substituent effects in the oxidation of 2-alkyl-1,4-dialkoxybenzenes with ceric ammonium nitrate
  作者：Brian E. Love、Alexander L. Simmons

  DOI：10.1016/j.tetlet.2016.11.042

  日期：2016.12

  Increased steric size of alkyl groups and the presence of coordinating atoms on alkoxy groups have both been found to contribute to decreasing yields of diquinones upon reaction of 2-alkyl-1,4-dialkoxybenzenes with CAN. The overall hydrophilicity of the substrates does not appear to be a significant factor in determining the diquinone yield for these reactions.

  已经发现，当2-烷基-1，4-二烷氧基苯与CAN反应时，增加的烷基空间尺寸和在烷氧基上存在配位原子均有助于降低二醌的收率。底物的整体亲水性似乎不是决定这些反应的二醌产率的重要因素。
• Nicotinamide Derivatives
  申请人：Blake Tanisha D.

  公开号：US20080146569A1

  公开（公告）日：2008-06-19

  The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.

  本发明涉及公式（I）的化合物及其药用可接受的盐和溶剂化合物，其中取代基如本文所定义，包含这种化合物的组合物以及这种化合物用于治疗各种疾病和状况，如哮喘。
• FAP Inhibitors
  申请人：Ferring B.V.

  公开号：EP1760076A1

  公开（公告）日：2007-03-07

  The present invention concerns compounds, according to general formula 1, which find utility, preferably for the treatment of cancer.

  本发明涉及化合物，符合一般式1，其主要用于治疗癌症。